Delivery Order SPE2DB22D2007-SPE2DB25FH8EM

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $2,242.95 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,133,907 units of Epinephrine 0.3 mg auto-injectors. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,730.69 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,564,675,611 units of epinephrine 0.15 mg auto-injectors. The contract has a firm fixed price and an ultimate completion date of May 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide epinephrine 0.3 mg auto-injectors. The $1,518.54 firm-fixed price contract has a completion date of May 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of...
The Defense Logistics Agency (DLA) awarded a delivery order worth $2,875.50 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,837,064 units of Epinephrine 0.3 mg auto-injectors. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of medical commodities to support military treatment programs and facilities...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of epinephrine 0.3 mg auto-injector products. The fixed-price contract has a ceiling value of $3,588.72 and a completion date of September 3, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of epinephrine 0.3 mg auto-injectors. The contract has a ceiling value of $1,702.59 and a period of performance through March 29, 2024. This delivery order is part of a broader indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injector devices. The contract has a ceiling value of $1,837.44 and an ultimate completion date of July 16, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of epinephrine 0.3 mg auto-injectors. The contract has a ceiling value of $10,388.39 and an ultimate completion date of November 3, 2023. It is a firm-fixed-price contract type. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
The Defense Logistics Agency (DLA) awarded a $1,550.76 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,749,613 units of epinephrine 0.3 mg auto-injector 2-packs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to supply a comprehensive range of medical commodities to support military treatment programs...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injector devices. The order has a ceiling value of $1,851.74 and a performance period ending on August 15, 2024. The contract is a firm-fixed price type with no set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH8EM
    Delivery Order

The federal government awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injector devices. The contract has a Firm Fixed Price pricing structure and a ceiling value of $5,192.92. The award was made by the Defense Logistics Agency (DLA), a defense agency, and the contract will run through January 13, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and expiring in November 2026. The IDC serves as a comprehensive vehicle for providing a range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 4/11/25, 11:02 AM